University of Chicago Medicine received a $75 million donation to help build a new cancer pavilion, officials announced.
The donation came from the AbbVie Foundation, a nonprofit dedicated to addressing health inequities. The pavilion — an $815 million, 575,000-square-foot building set to open in 2027 — will be named after the nonprofit.
“We are deeply honored by this generous donation, as it strengthens our commitment to advancing the health and vitality of the community — a core priority of our South Side-based institution,” said Paul Alivisatos, president of the University of Chicago. “This significant contribution speaks to the confidence that the AbbVie Foundation has in UChicago as a pioneering medical institution dedicated to pursuing globally meaningful solutions to yet-unsolved challenges.”
Health system officials said the new center will streamline the process for patients receiving care, consolidating services that are currently spread across at least five buildings on the Hyde Park campus.
Plans for the center were first announced in 2022 with an estimated price tag of $633 million. Officials said the updated price tag includes patient-focused enhancements that reflect their needs.
“This facility is not just about advancing scientific discovery, though that is certainly a key part of our mission,” Mark Anderson, executive vice president for medical affairs at UChicago, said. “It’s about transforming how we deliver care, addressing the inequities that exist in cancer outcomes, and ensuring that everyone — no matter their background — has access to the most advanced treatments.”
Contributing: Emmanuel Camarillo